Cargando…

Canagliflozin Ameliorates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism and Inhibiting Inflammation through Induction of Autophagy

PURPOSE: Nonalcoholic fatty liver disease (NAFLD) is closely associated with metabolic diseases, including obesity and diabetes, and has gradually become the most common cause of chronic liver disease. We investigated the effects of sodium glucose cotransporter 2 (SGLT2) inhibitor canagliflozin on N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Zhipeng, Hu, Wenxin, Wang, Bin, Xu, Ting, Wang, Jianning, Wei, Dan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Yonsei University College of Medicine 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226837/ https://www.ncbi.nlm.nih.gov/pubmed/35748073 http://dx.doi.org/10.3349/ymj.2022.63.7.619

Ejemplares similares

Efficacy of canagliflozin against nonalcoholic fatty liver disease: a prospective cohort study
por: Itani, Toshio, et al.
Publicado: (2018)

Puerarin ameliorates nonalcoholic fatty liver in rats by regulating hepatic lipid accumulation, oxidative stress, and inflammation
por: Zhou, Jingxuan, et al.
Publicado: (2022)

An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
por: Pei, Ke, et al.
Publicado: (2020)

Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease via the Sirt1/AMPK and NF-κB signaling pathways
por: Li, Chun-Xiao, et al.
Publicado: (2019)

Ficus hirta Vahl. Ameliorates Nonalcoholic Fatty Liver Disease through Regulating Lipid Metabolism and Gut Microbiota
por: Quan, Ting, et al.
Publicado: (2022)

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

LY6D is crucial for lipid accumulation and inflammation in nonalcoholic fatty liver disease
por: Lee, Jibeom, et al.
Publicado: (2023)

Myeloid-specific blockade of Notch signaling ameliorates nonalcoholic fatty liver disease in mice
por: Ding, Jian, et al.
Publicado: (2023)

Autophagy: a new target for nonalcoholic fatty liver disease therapy
por: Mao, Yuqing, et al.
Publicado: (2016)

Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation
por: Wu, You, et al.
Publicado: (2021)

Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
por: Hall, Zoe, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism
por: Zhou, Tingting, et al.
Publicado: (2023)

Berberine ameliorates nonalcoholic fatty liver disease by decreasing the liver lipid content via reversing the abnormal expression of MTTP and LDLR
por: Chen, Ping, et al.
Publicado: (2021)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
por: Yang, Xiao-Fang, et al.
Publicado: (2021)

Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease
por: Mukai, Takako, et al.
Publicado: (2017)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Eight Zhes Decoction ameliorates the lipid dysfunction of nonalcoholic fatty liver disease using integrated lipidomics, network pharmacology and pharmacokinetics
por: Zhou, Yuping, et al.
Publicado: (2023)

Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion
por: Minami, Yoshito, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
por: Fon Tacer, Klementina, et al.
Publicado: (2011)

Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
por: Bhat, Neha, et al.
Publicado: (2023)

Inhibition of TREM‐1 attenuates inflammation and lipid accumulation in diet‐induced nonalcoholic fatty liver disease
por: Rao, Shenzong, et al.
Publicado: (2019)

Dietary Valine Ameliorated Gut Health and Accelerated the Development of Nonalcoholic Fatty Liver Disease of Laying Hens
por: Jian, Huafeng, et al.
Publicado: (2021)

Structural and Functional Modulation of Gut Microbiota by Jiangzhi Granules during the Amelioration of Nonalcoholic Fatty Liver Disease
por: Wang, Rui-rui, et al.
Publicado: (2021)

Garlic-Derived S-Allylmercaptocysteine Ameliorates Nonalcoholic Fatty Liver Disease in a Rat Model through Inhibition of Apoptosis and Enhancing Autophagy
por: Xiao, Jia, et al.
Publicado: (2013)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Canagliflozin mitigates ferroptosis and ameliorates heart failure in rats with preserved ejection fraction
por: Ma, Sai, et al.
Publicado: (2022)

Canagliflozin Inhibits Human Endothelial Cell Inflammation through the Induction of Heme Oxygenase-1
por: Peyton, Kelly J., et al.
Publicado: (2022)

The Role of Thiazolidinediones in the Amelioration of Nonalcoholic Fatty Liver Disease: A Systematic Review
por: Ndakotsu, Andrew, et al.
Publicado: (2022)

Quinoa Ameliorates Hepatic Steatosis, Oxidative Stress, Inflammation and Regulates the Gut Microbiota in Nonalcoholic Fatty Liver Disease Rats
por: Zhong, Lingyue, et al.
Publicado: (2023)

Empagliflozin activates Sestrin2-mediated AMPK/mTOR pathway and ameliorates lipid accumulation in obesity-related nonalcoholic fatty liver disease
por: Ma, Yuting, et al.
Publicado: (2022)

Exercise in mice ameliorates high-fat diet-induced nonalcoholic fatty liver disease by lowering HMGCS2
por: Qian, Xiaoli, et al.
Publicado: (2021)

Genipin Ameliorates Carbon Tetrachloride-Induced Liver Injury in Mice via the Concomitant Inhibition of Inflammation and Induction of Autophagy
por: Wang, Ya, et al.
Publicado: (2019)

Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease
por: Chang, Xinxia, et al.
Publicado: (2016)

Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients
por: Zeybel, Mujdat, et al.
Publicado: (2021)

Chitosan Oligosaccharide Ameliorates Nonalcoholic Fatty Liver Disease (NAFLD) in Diet-Induced Obese Mice
por: Qian, Minyi, et al.
Publicado: (2019)

Cord Blood Adipokines and Lipids and Adolescent Nonalcoholic Fatty Liver Disease
por: Simpson, Joy, et al.
Publicado: (2016)

Cisd2 Protects the Liver from Oxidative Stress and Ameliorates Western Diet-Induced Nonalcoholic Fatty Liver Disease
por: Huang, Yi-Long, et al.
Publicado: (2021)

Amelioration by Idesia polycarpa Maxim. var. vestita Diels. of Oleic Acid-Induced Nonalcoholic Fatty Liver in HepG2 Cells through Antioxidant and Modulation of Lipid Metabolism
por: Li, Na, et al.
Publicado: (2020)

Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease
por: Bibbò, Stefano, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ram0mvvhm3gcukhpnhmhvoojh